Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InSMART-school: IPTsc for Malaria
NCT03640403Phase 3Completed
- Sponsor
- National Institute for Medical Research
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine, artesunate + amodiaquine in malaria, sponsored by National Institute for Medical Research. Started Mar 2019; status: completed.
02
Drugs
dihydroartemisinin + piperaquineartesunate + amodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03640403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640403.